Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
Abstract Background Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden of 1.2 million pediatric malaria cas...
Saved in:
Main Authors: | Kathryn D. Jackson (Author), Colleen R. Higgins (Author), Sarah K. Laing (Author), Chiluba Mwila (Author), Tamaki Kobayashi (Author), Matthew M. Ippolito (Author), Sean Sylvia (Author), Sachiko Ozawa (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019) -
Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
by: Elizabeth Pisani, et al.
Published: (2021) -
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021)